Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer

被引:23
|
作者
Obeng-Gyasi, Samilia [1 ]
Li, Yaming [2 ]
Carson, William E. [1 ]
Reisenger, Sarah [3 ]
Presley, Carolyn J. [3 ]
Shields, Peter G. [3 ]
Carbone, David P. [3 ]
Ceppa, DuyKhanh P. [4 ]
Carlos, Ruth C. [5 ]
Andersen, Barbara L. [6 ]
机构
[1] Ohio State Univ, Dept Surg, Div Surg Oncol, 410 W 10th Ave,Room N924 Doan Hall, Columbus, OH 43210 USA
[2] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA
[3] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[4] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[5] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[6] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
NATIONAL SAMPLE; WOMENS HEALTH; SURVIVAL; SCORE; ADAPTATION; DISEASE; STRESS;
D O I
10.1001/jamanetworkopen.2022.21626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Adverse social determinants of health (SDHs) (eg, poverty) are associated with poor oncologic outcomes among patients with lung cancer. However, no studies have evaluated biological correlates of adverse SDHs, operationalized as allostatic load (AL), with mortality due to lung cancer. OBJECTIVE To examine the association among AL, SDHs, and mortality among patients with metastatic non-small cell lung cancer (NSCLC). DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study of an observational cohort was performed at a National Cancer Institute-designated comprehensive cancer center with data accrued from June 1, 2017, to August 31, 2019. Patients with metastatic (stage IV) NSCLC enrolled at diagnosis into a prospective observational cohort study were included in the present analysis if they had all the biomarkers to calculate an AL score (N = 143). Follow-up was completed on August 31, 2021, and data were analyzed from July 1 to September 30, 2021. EXPOSURES Social determinants of health. MAIN OUTCOMES AND MEASURES Overall mortality and AL. RESULTS A total of 143 patients met the study criteria with a median age of 63 (IQR, 55-71) years (89 men [62.2%] and 54 women [37.8%]). In terms of race and ethnicity, 1 patient (0.7%) was Asian, 7 (4.9%) were Black, 117 (81.8%) were White, 17 (11.9%) were of multiple races, and 1 (0.7%) was of other race or ethnicity. The mean (SD) AL was 2.90 (1.37). Elevated AL covaried with lower educational level (r = -0.26; P = .002), male sex (r = 0.19; P = .02), limited mobility (r = 0.19; P = .04), worsening self-care (r = 0.30; P < .001), problems engaging in usual activities (r = 0.21; P = .01), depressive symptoms (r = 0.23; P = .005), and a high number of stressful life events (r = 0.30; P < .001). Multivariable analysis found only increasing difficulty with mobility (r = 0.37 [95% CI, 0.13-0.60]; P = .002) and male sex (r = 0.63 [95% CI, 0.19-1.08]; P = .005) associated with higher AL. On adjusted analysis, elevated AL (hazard ratio, 1.43 [95% CI, 1.16-1.79]; P = .001) and low educational level (hazard ratio, 2.11 [95% CI, 1.03-4.34]; P = .04) were associated with worse overall mortality. CONCLUSIONS AND RELEVANCE The findings of this cross-sectional study suggest that higher AL was associated with adverse SDHs and worse overall mortality among patients with advanced NSCLC. These results provide a framework for replication and further studies of AL as a biological correlate for SDH and future prognostic marker.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Association of allostatic load with overall mortality among patients with metastatic non-small cell lung cancer (vol 5, e2221626, 2022)
    Obeng-Gyasi, S.
    Li, Y.
    Carson, W. E.
    JAMA NETWORK OPEN, 2023, 6 (03)
  • [2] Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer
    Goyal, Gaurav
    Kommalapati, Anuhya
    Bartley, Adam C.
    Gunderson, Tina M.
    Adjei, Alex A.
    Go, Ronald S.
    LUNG CANCER, 2018, 122 : 214 - 219
  • [3] Association of Stage Shift and Population Mortality Among Patients With Non-Small Cell Lung Cancer
    Flores, Raja
    Patel, Parth
    Alpert, Naomi
    Pyenson, Bruce
    Taioli, Emanuela
    JAMA NETWORK OPEN, 2021, 4 (12)
  • [4] Association between hospital volume and overall survival of patients with metastatic non-small cell lung cancer.
    Goyal, Gaurav
    Bartley, Adam C.
    Go, Ronald S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Prognostic Factors for Overall Survival among Patients with Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Verleger, Katharina
    Treur, Maarten
    Penrod, John
    Daumont, Melinda
    Lees, Michael
    Macahilig, Cynthia
    Solem, Caitlyn
    Jiang, Shan
    Chirita, Oana
    Hertel, Nadine
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S995 - S996
  • [6] Biomarker Testing and Overall Survival among Patients Diagnosed with Advanced or Metastatic Non-small Cell Lung Cancer
    Hess, L.
    Beyrer, J.
    Abedtash, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S79 - S79
  • [7] Association of Venous Thromboembolism and Early Mortality in Patients with Newly Diagnosed Metastatic Non-Small Cell Lung Cancer
    Su, Yanping
    Huo, Meirong
    Hua, Lin
    Zhang, Yuan
    Yi, Jiawen
    Zhang, Shu
    Li, Jie
    Zhang, Yuhui
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4031 - 4040
  • [8] Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non-Small Cell Lung Cancer
    Su, Chloe C.
    Wu, Julie T.
    Choi, Eunji
    Myall, Nathaniel J.
    Neal, Joel W.
    Kurian, Allison W.
    Stehr, Henning
    Wood, Douglas
    Henry, Solomon M.
    Backhus, Leah M.
    Leung, Ann N.
    Wakelee, Heather A.
    Han, Summer S.
    JAMA NETWORK OPEN, 2023, 6 (09) : E2335813
  • [9] ASSOCIATION BETWEEN TUMOR HETEROGENEITY AND OVERALL SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Song, Jiangdian
    Dong, Di
    Huang, Yanqi
    Liu, Zaiyi
    Tian, Jie
    2016 IEEE 13TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2016, : 1249 - 1252
  • [10] Immunotherapy and Overall Survival Among Patients With Advanced Non-Small Cell Lung Cancer and Obesity
    Ihara, Yasutaka
    Sawa, Kenji
    Imai, Takumi
    Bito, Tsubasa
    Shimomura, Yuki
    Kawai, Ryota
    Shintani, Ayumi
    JAMA NETWORK OPEN, 2024, 7 (08)